Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00935311 · ClinicalTrials.gov registry record · Phase 2
Hydrocodone/Acetaminophen for Acute Pain Following Third Molar Tooth Extraction
A Phase 2 study, sponsored by AbbVie (prior sponsor, Abbott).
- Completed
- Registry status
- Phase 2
- Development phase
- 122
- Enrollment target
NCT00935311 is a Phase 2 study that has completed, run by AbbVie (prior sponsor, Abbott). The registered enrollment target is 122 participants.
The verdict
NCT00935311, a Phase 2 study, has completed, sponsored by AbbVie (prior sponsor, Abbott).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 122 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate analgesic efficacy and safety of hydrocodone/acetaminophen compared to placebo in moderate to severe pain following molar extraction.
Interventions
- DRUG Placebo
- DRUG ABT-712 Extended-release
- DRUG Hydrocodone/Acetaminophen Immediate-release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2009-06 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00935311
The ClinicalTrials.gov registry entry for NCT00935311 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AbbVie (prior sponsor, Abbott), which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00935311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00935311 about?
NCT00935311 is a clinical study titled "Hydrocodone/Acetaminophen for Acute Pain Following Third Molar Tooth Extraction". The purpose of this study was to evaluate analgesic efficacy and safety of hydrocodone/acetaminophen compared to placebo in moderate to severe pain following molar extraction.
What is the current status of trial NCT00935311?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 122 participants. The study started on 2009-06. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00935311?
The interventions under investigation include: Placebo (DRUG), ABT-712 Extended-release (DRUG), Hydrocodone/Acetaminophen Immediate-release (DRUG).
Who is sponsoring clinical trial NCT00935311?
This trial is sponsored by AbbVie (prior sponsor, Abbott), which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.